CID 169502287

Sildenafil metabolite m7

Structural Information

Molecular Formula
C21H28N6O5S
SMILES
CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCNC(=O)C)OCC)C
InChI
InChI=1S/C21H28N6O5S/c1-5-7-16-18-19(27(4)26-16)21(29)25-20(24-18)15-12-14(8-9-17(15)32-6-2)33(30,31)23-11-10-22-13(3)28/h8-9,12,23H,5-7,10-11H2,1-4H3,(H,22,28)(H,24,25,29)
InChIKey
ZYWPXPKXOKVJLI-UHFFFAOYSA-N
Compound name
N-[2-[[4-ethoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,5-d]pyrimidin-5-yl)phenyl]sulfonylamino]ethyl]acetamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

476.1842 Da
Monoisotopic Mass

0.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 477.191476 214.2
[M+Na]+ 499.173418 222.7
[M-H]- 475.176924 216.7
[M+NH4]+ 494.218023 219.2
[M+K]+ 515.147358 216.4
[M+H-H2O]+ 459.181460 205.1
[M+HCOO]- 521.182401 227.1
[M+CH3COO]- 535.198051 238.2
[M+Na-2H]- 497.158866 215.4
[M]+ 476.18365142 222.7
[M]- 476.18474858 222.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.